BRPI1009814A2 - Uso de estigmasterol, e, composição. - Google Patents

Uso de estigmasterol, e, composição.

Info

Publication number: BRPI1009814A2
Authority: BR; Brazil
Prior art keywords: stigmasterol; composition
Prior art date: 2009-03-12

Application number

BRPI1009814-3A

Other languages

English (en)

Inventor

Marcus Otto Walter Grimm

Tobias Hartmann

Petra Frieb-Javorkova

Ulrich Laufs

Oliver Weingärtner

Original Assignee

Nutricia Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-12

Filing date

2010-03-12

Publication date

2015-08-25

2010-03-12 Application filed by Nutricia Nv filed Critical Nutricia Nv

2015-08-25 Publication of BRPI1009814A2 publication Critical patent/BRPI1009814A2/pt

Links

OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 title 1
OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 title 1
HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 title 1
LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 title 1
HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 title 1
229940032091 stigmasterol Drugs 0.000 title 1
BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 title 1
235000016831 stigmasterol Nutrition 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Botany (AREA)
Public Health (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Mycology (AREA)
Nutrition Science (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI1009814-3A 2009-03-12 2010-03-12 Uso de estigmasterol, e, composição. BRPI1009814A2 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
NL2009050121		2009-03-12
PCT/NL2009/050315 WO2010104375A1 (en)	2009-03-12	2009-06-08	Stigmasterol for the treatment of alzheimer's disease
PCT/NL2010/050133 WO2010104394A1 (en)	2009-03-12	2010-03-12	Stigmasterol for the treatment of alzheimer's disease

Publications (1)

Publication Number	Publication Date
BRPI1009814A2 true BRPI1009814A2 (pt)	2015-08-25

Family

ID=41172380

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1009814-3A BRPI1009814A2 (pt)	2009-03-12	2010-03-12	Uso de estigmasterol, e, composição.

Country Status (4)

Country	Link
EP (1)	EP2405773A1 (pt)
CN (1)	CN102421304A (pt)
BR (1)	BRPI1009814A2 (pt)
WO (2)	WO2010104375A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN104398523B (zh) *	2014-11-03	2017-01-25	南昌大学	(22反式)‑3β‑羟基‑胆甾‑5,22‑二烯‑24‑酮在神经保护药物中的应用
JP7073330B2 (ja)	2016-07-25	2022-05-23	ウィスタラボラトリーズリミテッド	ジアミノフェノチアジンの投与及び投与量
CN109793783A (zh) *	2017-11-16	2019-05-24	西双版纳华坤生物科技有限责任公司	一种用于阿尔兹海默症预防与治疗物质的应用及制备方法
FI4385512T3 (fi) *	2018-07-26	2026-01-12	Taurx Therapeutics Man Ltd	Diaminofenotiatsiinien optimoitu annostus populaatioille

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6346280B1 (en) *	1997-05-15	2002-02-12	University Of Washington	Composition and methods for inhibiting the formation of brain amyloid deposits
US5985936A (en) *	1997-12-18	1999-11-16	Forbes Medi-Tech, Inc.	Method of preventing and delaying onset of Alzheimer's disease and composition therefor
AU1995400A (en) *	1999-01-15	2000-08-01	Nutrahealth Ltd (Uk)	Modified food products and beverages, and additives for food and beverages
ATE239490T1 (de) *	1999-07-09	2003-05-15	Bsp Pharma As	Zusammensetzung enthaltend butyrospermum parkii extrakte und die verwendung als arzneimittel oder nahrungszusatz
US20060078533A1 (en)	2004-10-12	2006-04-13	Omoigui Osemwota S	Method of prevention and treatment of aging and age-related disorders including atherosclerosis, peripheral vascular disease, coronary artery disease, osteoporosis, arthritis, type 2 diabetes, dementia, alzheimer's disease and cancer
SG152271A1 (en)	2003-10-24	2009-05-29	Nutricia Nv	Immunemodulating oligosaccharides
EP1682154B1 (en) *	2003-10-24	2010-08-04	The Coca-Cola Company	Process for preparing phytosterol dispersions for application in beverages
US20050214370A1 (en) *	2004-03-26	2005-09-29	Sarama Robert J	Stable coating agent comprising sterol
EP2020874A4 (en) *	2006-05-01	2015-07-15	Pharmachem Lab Inc	COMPOSITION COMPRISING ONE OR MORE EXTRACTED PHYTOSTEROLS AND / OR PHYTOSTANOLES IN WHICH ONE OR MORE NON-SELECTED PHYTOSTEROLS AND / OR PHYTOSTANOLES ARE SOLUBILIZED TO OBTAIN THERAPEUTIC ADVANTAGES AND FORMULATION BENEFITS
EP2036444A1 (en) *	2007-09-05	2009-03-18	Dietetics Pharma S.r.l.	Liquid nutraceutic preparation containing free plant sterols

2009
- 2009-06-08 WO PCT/NL2009/050315 patent/WO2010104375A1/en not_active Ceased
2010
- 2010-03-12 CN CN2010800202802A patent/CN102421304A/zh active Pending
- 2010-03-12 BR BRPI1009814-3A patent/BRPI1009814A2/pt not_active IP Right Cessation
- 2010-03-12 EP EP10708409A patent/EP2405773A1/en not_active Withdrawn
- 2010-03-12 WO PCT/NL2010/050133 patent/WO2010104394A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2010104394A1 (en)	2010-09-16
EP2405773A1 (en)	2012-01-18
CN102421304A (zh)	2012-04-18
WO2010104375A1 (en)	2010-09-16

Similar Documents

Publication	Publication Date	Title
BRPI0813627A2 (pt)	2014-12-23	Peptídio antimicrobiano, composições e métodos de uso
BRPI0912717A2 (pt)	2014-12-23	Composição farmacêutica, e, uso de 5-azacitidina
BR112012004335A2 (pt)	2015-09-08	composto, composição farmacêutica, e, uso do composto.
BR112012002349A2 (pt)	2015-10-13	composto,e, uso do mesmo
BRPI0908792A2 (pt)	2015-07-21	Composição, e, uso de uma combinação
BRPI1014316A2 (pt)	2016-04-05	composição, e, uso de uma composição
BRPI0919438A2 (pt)	2015-12-15	mistura de poliésteres, e, uso das misturas de poliésteres
BRPI1012861A2 (pt)	2018-02-27	catalisador, e, uso do catalisador
PT2585437E (pt)	2014-04-29	Compostos de tioacetato, composições e métodos de uso
BR112012003792A2 (pt)	2016-04-19	gel tópico, e, uso do gel tópico.
BRPI1007018A2 (pt)	2016-03-29	composto, composição farmacêutica, e , uso de um composto.
BR112012002331A2 (pt)	2019-09-24	composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BRPI1012533A2 (pt)	2015-09-22	composto de piradazinona e uso do mesmo
BRPI1013421A2 (pt)	2016-04-05	composição parasticida tópica, e, uso de uma composição
BRPI1006996A2 (pt)	2015-09-15	composição, método e uso
BRPI1005292A2 (pt)	2016-03-22	composição de decapagem e uso da composição
FR2943680B1 (fr)	2012-12-28	Composition de caoutchoux et pneumatique utilisant cette composition.
BRPI1011423A2 (pt)	2016-03-15	composição injetável, kit e método cosmético.
BRPI1008906A2 (pt)	2016-03-15	composto, composição farmacêutica, e, uso de um composto.
BRPI0913739A2 (pt)	2015-08-18	Composição líquida, método, e, uso de composição
BR112013006016A2 (pt)	2016-06-07	compostos de azabenzotiazol, composições e métodos de uso
BRPI1005670A8 (pt)	2017-12-26	composições adjuvantes e processos de uso.
BR112012031226A2 (pt)	2018-03-06	composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112012005736A2 (pt)	2016-03-08	di-hidro benzocicloalquiloximetil oxazolapirimidinonas substituídas, preparação e uso das mesmas
BRPI0914793A2 (pt)	2015-08-04	Composição, e, uso de uma composição

Legal Events

Date	Code	Title	Description
2015-12-08	B08F	Application fees: dismissal - article 86 of industrial property law	Free format text: REFERENTE AS 4A E 5A ANUIDADES.
2016-04-05	B08K	Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.
2018-03-27	B15K	Others concerning applications: alteration of classification	Ipc: A61K 31/575 (2006.01), A23L 33/11 (2016.01)